AKI in SARS-CoV-2 infection

The letter below is a request to any GEITP clinicians (pulmonologists, cardiologists or GI specialists) who know of someone who is, or who are, treating a substantial number of COVID-19 patients. Professor Soleimani ( Univ of New Mexico in Albuquerque.) is looking for potential collaborators with whom his group might interact.

Dear Colleagues,

The attached article is a commentary and emphasizes the role of kidney proximal tubule-specific priming proteases, and the fact that they are different from those in alveolar cells in mediating acute kidney injury (AKI) in SARS-CoV-2 infections. Trying to exploit the proximal tubule cell milieu and molecular machinery to combat SARS-CoV-2 invasion of kidney tubular cells — is a challenging task. 😊

We are currently doing research on some of these pathways in cultured kidney proximal tubule cells and are looking to interact with clinicians (pulmonologists, cardiologists or GI specialists) who are treating a substantial number of COVID 19 patients. Any suggestions would be appreciated.

Warm regards,

DwN

This entry was posted in Center for Environmental Genetics. Bookmark the permalink.